Considerations for Design and Use of Container Challenge Sets for Qualification and Validation of Visible Particulate Inspection | PDA Journal of Pharmaceutical Science and Technology

References

1.↵
USP (USP) Particulate Matter in Injections, 〈788〉; Particulate Matter in Ophthalmic Solutions 〈789〉; Methods for the Determination of Particulate Matter in Injections and Ophthalmic Solutions, 〈1788〉, USP 34-NF 29, 2011.
Google Scholar
2.
European Pharmacopeia (EP): Particulate Contamination: Sub-visible Particles; Method 2.9.20, 6.0, 1, 302, 2011.
Google Scholar
3.
British Pharmacopeia (BP). Appendix XIII B. Particulate Contamination: Visible Particles; Ph. Eur. Method 2.9.20, I, A322, 2011.
Google Scholar
4.↵
Japanese Pharmacopoeia (JP). Insoluble Particulate Matter Test for Injections: The Ministry of Health, Labor and Welfare Ministerial Notification No. 285, 15, 6.07, 110, 2007.
Google Scholar
5.↵
Guidance for Industry. Container Closure Systems for Packaging, Human Drugs and Biologics, Chemistry, Manufacturing and Controls Documentation, FDA, May 1999.
Google Scholar
6.
Technical Report No. 43. Identification and Classification of Nonconformities in Molded and Tubular Glass Containers for Pharmaceutical Manufacturing. PDA J. Pharm. Sci. Technol. 2007, 61, 1– 31.
OpenUrl Abstract/FREE Full Text Google Scholar
7.↵
Technical Report No. 27. Pharmaceutical Package Integrity Identification and Classification of Nonconformities in Molded and Tubular Glass Containers for Pharmaceutical Manufacturing. PDA J. Pharm. Sci. Technol. 1998, 52, 1– 48.
OpenUrl PubMed Google Scholar
8.↵
1. Knapp J. Z.,
2. Kushner H. K.
Generalized methodology for evaluation of parenteral inspection procedures. J. Parent. Drug Assoc. 1980, 34 (1), 14– 61.
OpenUrl Google Scholar
9.↵
1. Cherris R
. Visual Inspection Lifecycle; Particulate and Container/Closure Defects. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2011.
Google Scholar
10.↵
1. Borchert S. J.,
2. Abe A.,
3. Aldrich S.,
4. Fox L. E.,
5. Freeman J. G.,
6. White R. W.
; Particulate matter in parenteral products: a review. J. Parent. Sci. Technol. 1986, 40 (5), 212– 241.
OpenUrl Google Scholar
11.↵
1. Melchore J. A.
Sound practices for consistent human visual inspection. AAPS PharmSciTech 2011, 12 (1), 215– 221.
OpenUrl PubMed Google Scholar
12.↵
1. Shabushnig J. G.,
2. Melchore J. G.,
3. Geiger M.,
4. Chrai S.,
5. Gerger M. E.
A Proposed Working Standard for the Validation of Particulate Inspection in Sterile Solutions. Paper presented at the PDA Annual Meeting, Philadelphia, PA, 1994.
Google Scholar
13.↵
1. Melchore J. A.
Establishing a Statistically Sound Manual Inspection Baseline. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
Google Scholar
14.↵
1. Melchore J. A.,
2. Berdovich D.
Design and Use of Challenge Sets for Inspection Studies. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2011.
Google Scholar
15.↵
1. Knapp J. Z.
The Bridge between Visible Particle Data and the Accuracy and Repeatability Requirements of PAT, One Safe Step at a Time. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2005.
Google Scholar
16.
1. Knapp J. Z.
The scientific basis for visible particle inspection. PDA J. Pharm. Sci. Technol. 1999, 53 (6), 291– 302.
OpenUrl Abstract/FREE Full Text Google Scholar
17.↵
1. Melchore J. A.
Prerequisites for optimized performance of the Eisai 1088W Automated Inspection System. PDA J. Pharm. Sci. Technol. 2010, 64 (6), 574– 580.
OpenUrl Abstract/FREE Full Text Google Scholar
18.
1. Knapp J. Z.,
2. Abramson L. R.
Automated particulate inspection systems: strategies and implications. J. Parent. Sci. Technol. 1990, 44, 74– 107.
OpenUrl Google Scholar
19.↵
1. Borchert S. J.,
2. Maxwell R. J.,
3. Davidson R. L.,
4. Aldrich D. S.
Standard particulate sets for visual inspection systems: their preparation, evaluation and applications. J. Parent. Sci. Technol. 1986, 40 (6), 265.
Google Scholar
20.↵
1. Leversee R. L.,
2. Shabushnig J. G.
A Survey of Industry Practice for the Visual Inspection of Injectable Products (PDA Preliminary Report). Paper presented at the PDA Visual Inspection Forum, Berlin, Germany, 2008.
Google Scholar
21.↵
1. Leversee R. L.,
2. Shabushnig J. G.
The Use of Standard Particles in the Qualification, Validation, and Routine Control of Visual Inspection Operations. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
Google Scholar
22.↵
1. Berdovich D.
Visual Inspection Standards. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2007.
Google Scholar
23.↵
1. Berdovich D.
Visual Inspection Standards. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2005.
Google Scholar
24.
1. Aldrich S.
, Particulate Matter—Visual Detection to Identification. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
Google Scholar
25.↵
1. Cherris R. T.
Visible Particle Inspection, Microscopy, and Characterization—Tools Supporting Visual Inspection Acceptance Criteria. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2005.
Google Scholar
26.↵
1. Rathore N.,
2. Chen C.,
3. Gonzalez O.,
4. Wenchang J.
Challenges and strategies for implementing automated visual inspection for biopharmaceuticals. Pharmaceutical Technology, Injectable Drug Delivery Supplement 2009, 33, S25– S29.
OpenUrl Google Scholar
27.↵
1. Singh S. K.,
2. Rathore N.,
3. McAuley A.,
4. Rathore A. S.
Best practices for formulation and manufacturing of biotech drug products. BioPharm Int. 2009, 22, 32– 48.
OpenUrl Google Scholar
28.↵
1. Shnek D,
2. Carrion-Martinez M.,
3. Gigh A.,
4. Segarra E.,
5. Bruno M,
6. Aquino A.,
7. Paranandi M.
Comparing Manual and Automated Inspection of Seeded Syringe Defects. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2007.
Google Scholar
29.↵
1. Gidh A.,
2. Carrion-Martinez M.,
3. Cai X.,
4. Paranandi M.,
5. Shnek D.
Particle Standard Sets for Automated Syringe Inspection. Paper presented at the PDA Visual Inspection Forum, Bethesda MD, 2007.
Google Scholar
30.↵
1. Deng S.,
2. Shnek D.,
3. Carrion-Martinez M.,
4. Dompenciel R.,
5. Baez L.,
6. Sullivan J.,
7. Sing N.,
8. Ruhl S.
Evaluation of Automated Visual Inspection (AVI) Technologies for Biologic Products. Paper presented at the PDA Annual Meeting, Las Vegas, NV, 2009.
Google Scholar
31.↵
1. Dunham A.
Visible Particulate Matter Detection in LVIs. Paper Presented at the PDA Annual Meeting, Colorado Springs, CO, April 2008.
Google Scholar
32.↵
1. McCormick S.,
2. Bariexca S.
Glass Sphere vs. Glass Shard Particle Detection Equivalency Using Automatic Static Division Inspection. Paper presented at the PDA Visual Inspection Forum, Berlin, Germany, 2010.
Google Scholar
33.↵
1. Grieb E.
Scrutinizing the Sub-Visible, Pharm. Technol. 2010, 35, 44– 48.
OpenUrl Google Scholar
34.↵
1. Berdovich D.
USP 〈788〉, USP 〈789〉 Issues in Measuring Particles. Paper presented at the USP Workshop on Particles, Rockville, MD, Dec. 8–10, 2010.
Google Scholar
35.↵
1. Knapp J. Z.
Overview of Accurate NIST Sized Dimensions of Visible Particle Contamination Data in Sealed Containers of Injectable Products: An Essential Validation and Product Acceptance Tool. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2007.
Google Scholar
36.↵
1. Budd G. W.
Referee Level NIST Traceable Particle Contaminating Particle Standards in Sealed Containers Used for the Creation of a Visible Calibration Curve. Paper presented at the PDA Visible Inspection Forum, Bethesda, MD, 2009.
Google Scholar
37.↵
1. Budd G. W.
Optimizing the Correlation of Automated Inspection Data Obtained from Electronic Sensors to (NIST Traceable) Referee Level Particle Standards. Paper presented at the PDA Visual Inspection Forum, Bethesda, MD, 2009.
Google Scholar
38.↵
1. Blackwell H. R.
Contrast thresholds of the human eye. J. Opt. Soc. Am. 1946, 36 (11), 624– 641.
OpenUrl CrossRef PubMed Web of Science Google Scholar